Comparison of the neuronal differentiation abilities of bone marrow-derived and adipose tissue-derived mesenchymal stem cells
Open Access
- 21 July 2017
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 16 (4) , 3877-3886
Abstract
Bone marrow‑derived mesenchymal stem cells (BMSCs) and adipose tissue‑derived mesenchymal stem cells (ADSCs) are able to differentiate into neuron‑like cells when exposed to small molecule compounds, however the specific differences in their neuronal differentiation abilities remain to be fully elucidated. The present study aimed to compare the neuronal differentiation abilities of BMSCs and ADSCs. BMSCs and ADSCs from the same Sprague Dawley rats were isolated and cultured for use. The proliferation capacity was revealed using a cell counting method. Following BMSCs and ADSCs induction by four types of small‑molecular compounds, the expression of various neuronal markers and the secretion of several neurotrophic factors were detected by immunofluorescence, western blotting, reverse transcription‑quantitative polymerase chain reaction and ELISA. It was demonstrated that the ADSCs exhibited an increased proliferation capacity compared with BMSCs, according to cumulative population doubling analyses. Following a 7‑day neuronal induction period, BMSCs and ADSCs exhibited a neuron‑like morphology, and were termed neuronal induced (NI)‑BMSCs and NI‑ADSCs. They expressed neuronal markers including β‑tubulin III, microtubule associated protein 2 and choline acetyltransferase. The number of NI‑BMSCs that positively expressed the neuronal markers was significantly decreased compared with NI‑ADSCs, and the expression and secretion of the neurotrophic factors nerve growth factor and 3'‑nucleotidase in NI‑BMSCs were additionally decreased compared with NI‑ADSCs. The findings of the present study indicated that the neuronal differentiation abilities and neurotrophic factor secretion abilities of ADSCs were increased compared with BMSCs. ADSCs may therefore act as efficient candidates in cell transplantation therapy for diseases and injuries of the nervous system.Keywords
This publication has 31 references indexed in Scilit:
- Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injuryNeuroscience, 2016
- Stem cells in articular cartilage regenerationJournal of Orthopaedic Surgery and Research, 2016
- Neuroprotective effects of mesenchymal stem cells on spinal motoneurons following ventral root axotomy: Synapse stability and axonal regenerationNeuroscience, 2013
- Mesenchymal Stem Cells/Multipotent Mesenchymal Stromal Cells (MSCs)The International Journal of Lower Extremity Wounds, 2012
- Transplanted Neurally Modified Bone Marrow–Derived Mesenchymal Stem Cells Promote Tissue Protection and Locomotor Recovery in Spinal Cord Injured RatsNeurorehabilitation and Neural Repair, 2011
- Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitroExperimental Neurology, 2007
- Culture and neural differentiation of rat bone marrow mesenchymal stem cells in vitroCell Biology International, 2007
- Neuron-like Differentiation of Adipose-Derived Stem Cells From Infant Piglets in VitroThe Journal of Spinal Cord Medicine, 2007
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueStem Cells, 2006
- Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,Bone, 2003